ACTIVE

APOTHEEK TER PLATEN

Export PDF

Financial year 2025 · Closed on 31/12/2025

Net result97,6 k €-18,9 %over 1 year

Gross margin388,5 k €+13,4 %over 1 year

Equity434,7 k €+21,7 %over 1 year

Workforce1,6 ETP+6,7 %over 1 year

Identity

Source · BCE/KBO

APOTHEEK TER PLATEN is a Private limited company incorporated in 1986. Its registered office is in Gent. It employs on average 1,6 ETP workers (FTE).

Legal situation: Normal situation
BCE/KBO no. / VAT: BE 0430.057.220
Incorporation: 19/12/1986
Legal form: Private limited company
Registered office: Tentoonstellingslaan 132
9000 Gent · FlandreSee on map
Contributed capital: 58 600,00 €
Latest accounts: 31/12/2025
Average workforce: 1,6 ETP

Joint committees (1)

Signals

ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 20 filings

Trend over 20 financial years

	2025		2024		2023		2022		2021
Income statement
Gross margin	388,5 k €	+13.4%	342,7 k €	+14.3%	299,9 k €	-13.7%	347,5 k €	+21.5%	286,1 k €
EBITDA	222,5 k €	-0.0%	222,6 k €	+3.7%	214,6 k €	-8.3%	234,1 k €	+38.2%	169,4 k €
Operating result	129 k €	-17.8%	156,9 k €	+2.1%	153,7 k €	-11.7%	174 k €	+59.7%	109 k €
Net result	97,6 k €	-18.9%	120,4 k €	+5.4%	114,3 k €	-17.7%	138,9 k €	+38.2%	100,5 k €
Balance sheet
Equity	434,7 k €	+21.7%	357,1 k €	+39.1%	256,6 k €	+58.1%	162,4 k €	+94.6%	83,4 k €
Total assets	1,7 M €	+83.5%	911,3 k €	+10.3%	826 k €	+0.3%	823,7 k €	+4.0%	792,3 k €
Cash	248 k €	+3.9%	238,6 k €	+2.1%	233,7 k €	+5.7%	221 k €	+13.8%	194,2 k €
Debts	1,2 M €	+123%	554,2 k €	-2.7%	569,3 k €	-13.9%	661,4 k €	-6.7%	708,8 k €
Other
Workforce	1,6 ETP	+6.7%	1,5 ETP	+7.1%	1,4 ETP		–		–

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€

See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 12 ended

Active mandates

BELIEPHARMA

Director · since 19 décembre 2023 · 0457.655.502

Represented by Van Laere Els

Active

LIBELCO Health

Director · since 19 décembre 2023 · 0784.376.147

Represented by De Belie Jan.

Active

Ended mandates

BELIEPHARMA

Director · since 19 décembre 2023 · 0457.655.502

Represented by Van LAERE ELS

Ended

BELIEPHARMA

Director · since 19 décembre 2023 · 0457.655.502

Represented by Jan De Belie

Ended

LIBELCO Health

Director · since 19 décembre 2023 · 0784.376.147

Represented by De BELIE JAN

Ended

BELIEPHARMA

Director · since 01 mai 2019 · 0457.655.502

Represented by Els Van Laere

Ended

Full financial information

Source · NBB

	2025	2024	2023	2022	2021	2020
Type of account	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model	Abridged model
Start of the financial year	01/01/2025	01/01/2024	01/01/2023	01/01/2022	01/01/2021	01/01/2020
Closing of the financial year	31/12/2025	31/12/2024	31/12/2023	31/12/2022	31/12/2021	31/12/2020
Length of the financial year	12 months	12 months	12 months	12 months	12 months	12 months
Filing date	30/06/2026	26/06/2025	03/06/2024	01/09/2023	30/09/2022	31/08/2021
General meeting	24/04/2026	30/05/2025	31/05/2024	26/05/2023	27/05/2022	28/05/2021
Currency of the financial year	EUR	EUR	EUR	EUR	EUR	EUR
NBB quality label	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls	Satisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 20 filings

Model	Closing	General meeting	Filed	Language	Document
Abridged model	31/12/2025	24/04/2026	30/06/2026	Dutch	PDF
Abridged model	31/12/2024	30/05/2025	26/06/2025	Dutch	PDF
Abridged model	31/12/2023	31/05/2024	03/06/2024	Dutch	PDF
Abridged model	31/12/2022	26/05/2023	01/09/2023	Dutch	PDF
Abridged model	31/12/2021	27/05/2022	30/09/2022	Dutch	PDF
Abridged model	31/12/2020	28/05/2021	31/08/2021	Dutch	PDF
Abridged model	31/12/2019	29/05/2020	11/06/2020	Dutch	PDF
Abridged model	31/12/2018	31/05/2019	30/08/2019	Dutch	PDF
Abridged model	31/12/2017	25/05/2018	19/06/2018	Dutch	PDF
Abridged model	31/12/2016	26/05/2017	20/07/2017	Dutch	PDF
Abridged model	31/12/2015	27/05/2016	20/07/2016	Dutch	PDF
Abridged model	31/12/2014	29/05/2015	14/08/2015	Dutch	PDF
Abridged model	31/12/2013	30/05/2014	27/06/2014	Dutch	PDF
Abridged model	31/12/2012	31/05/2013	28/08/2013	Dutch	PDF
Abridged model	31/12/2011	25/05/2012	29/08/2012	Dutch	PDF
Abridged model	31/12/2010	30/06/2011	14/07/2011	Dutch	PDF
Abridged model	31/12/2009	28/05/2010	25/06/2010	Dutch	PDF
Abridged model	31/12/2008	30/06/2009	17/07/2009	Dutch	PDF
Abridged model	31/12/2007	30/05/2008	25/06/2008	Dutch	PDF
Abridged model	31/12/2006	31/05/2007	28/06/2007	Dutch	PDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan

Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

2 active · 12 ended

Active mandates

BELIEPHARMA

Director · since 19 décembre 2023 · 0457.655.502

Represented by Van Laere Els

Active

LIBELCO Health

Director · since 19 décembre 2023 · 0784.376.147

Represented by De Belie Jan.

Active

Ended mandates

BELIEPHARMA

Director · since 19 décembre 2023 · 0457.655.502

Represented by Van LAERE ELS

Ended

BELIEPHARMA

Director · since 19 décembre 2023 · 0457.655.502

Represented by Jan De Belie

Ended

LIBELCO Health

Director · since 19 décembre 2023 · 0784.376.147

Represented by De BELIE JAN

Ended

BELIEPHARMA

Director · since 01 mai 2019 · 0457.655.502

Represented by Els Van Laere

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette

Other23/09/2026
—
PDF
Restructuring28/07/2026
RUBRIEK HERSTRUCTURERING (FUSIE, SPLITSING, OVERDRACHT VERMOGEN, ENZ...)
PDF
Mandates10/01/2024
STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, ) - WIJZIGING RECHTSVORM - ONTSLAGEN - BENOEMINGEN
PDF
Mandates10/03/2022
ONTSLAGEN - BENOEMINGEN
PDF
Mandates20/01/2011
BENAMING - KAPITAAL - AANDELEN - ONTSLAGEN - BENOEMINGEN
PDF
Capital / shares17/01/2007
KAPITAAL - AANDELEN - ALGEMENE VERGADERING - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF
Capital / shares26/02/2004
ALGEMENE VERGADERING - KAPITAAL - AANDELEN - STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, )
PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

2025
Annual accounts 202597,6 k €↓
2024
Annual accounts 2024120,4 k €↑
2023
Annual accounts 2023114,3 k €↓
2022
Annual accounts 2022138,9 k €↑
2021
Annual accounts 2021100,5 k €↑
2021
Name changeAPOTHEEK TER PLAETEN
2020
Annual accounts 202073,3 k €↑
2019
Annual accounts 201953,5 k €↑
2018
Annual accounts 201850,8 k €↓
2017
Annual accounts 201767 k €↑
2016
Annual accounts 201637,5 k €↓
2015
Annual accounts 201545,2 k €↑
2014
Annual accounts 201436,5 k €↑
2013
Annual accounts 201321,5 k €↑
2012
Annual accounts 20129,7 k €↑
2011
Annual accounts 2011-74,3 k €↓
2010
Annual accounts 201066,2 k €↑
2010
Name changeApotheek Ter Platen
2009
Annual accounts 200946,8 k €↑
2008
Annual accounts 200845,3 k €↓
2007
Annual accounts 200763,8 k €↑
2006
Annual accounts 200647,7 k €
2006
Name changeAPOTHEEK PARMENTIER R.
19/12/1986
IncorporationPrivate limited company

APOTHEEK TER PLATEN

Overview

Identity

Financials

Valuation

Indicative valuation

Board of directors

Financials

Full financial information

Financial ratios

Annual accounts filings

Valuation

Indicative valuation

Directors & structure

Board of directors

Ownership and network

Publications

Belgian Official Gazette publications

Similar companies

Similar companies

Timeline

Timeline